Our Portfolio Companies' Press Releases
Infusion 51a co-founded company Vivacitas Oncology closes $1 million from DSS as it explores going public
DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology ROCHESTER, N.Y., August 2, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc.
Vivacitas Oncology and IAG Partner to Integrate Novel Imaging Markers in the Development of AR-67 in Recurrent Glioblastoma Patients – IAG
[WALNUT CREEK, CALIFORNIA, US AND LONDON, UK, May 3, 2021] – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a clinical stage biopharmaceutical company focused on
DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology
DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology ROCHESTER, N.Y., April 08, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the
Theralink® Technologies Achieves California CLIA Clinical and Public Health Certification
Denver, Colorado – March 29th, 2021 – Theralink Technologies, Inc. (OTC: OBMP), a precision medicine and molecular profiling company specializing in patented, biomarker assay services
Theralink® Technologies Moves Closer Toward Changing the Standard of Care for All Women Newly Diagnosed with HER2+ Breast Cancer
George Mason University and Rutgers Cancer Institute of New Jersey Name Theralink Technologies as the Commercial Provider of Critical Assay DENVER – February 22, 2021
Theralink® Technologies closer to potentially becoming the Standard of Care in Breast Cancer
George Mason University and Rutgers Cancer Institute of New Jersey Name Theralink Technologies as the Commercial Provider of Critical Assay DENVER – February 22, 2021